2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow halobetasol: new trials by email Literature Review of halobetasol trials Research Report on halobetasol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis 0.01% Halobetasol, 0.045% Tazarotene, 0.05% Clobetasol Propionate - Psoriasis Vulgaris | Phase 4 | Completed | Dermatology Consulting Services, PLLC | 10 | 2023-07-13 | 2023-11-18 |
| Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis Duobrii® - Palmoplantar Psoriasis, Plaque Psoriasis | Phase 4 | Completed | Icahn School of Medicine at Mount Sinai | 22 | 2020-11-19 | 2023-10-27 |
Plaque, Amyloid (1) · Psoriasis (1)
Dermatology Consulting Services, PLLC (1) · Icahn School of Medicine at Mount Sinai (1)
United States (2)